quinaprilat has been researched along with 5-hydroxydecanoate in 1 studies
Studies (quinaprilat) | Trials (quinaprilat) | Recent Studies (post-2010) (quinaprilat) | Studies (5-hydroxydecanoate) | Trials (5-hydroxydecanoate) | Recent Studies (post-2010) (5-hydroxydecanoate) |
---|---|---|---|---|---|
92 | 23 | 4 | 431 | 0 | 93 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, M; Chen, X; Fujiwara, H; Lu, C; Minatoguchi, S; Misao, Y; Takemura, G; Uno, Y; Wang, N | 1 |
1 other study(ies) available for quinaprilat and 5-hydroxydecanoate
Article | Year |
---|---|
Quinaprilat reduces myocardial infarct size involving nitric oxide production and mitochondrial KATP channel in rabbits.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Decanoic Acids; Heart Ventricles; Hemodynamics; Hydroxy Acids; Hydroxyl Radical; Male; Membrane Proteins; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Potassium Channel Blockers; Potassium Channels; Rabbits; Tetrahydroisoquinolines | 2003 |